BCA
PCYC

Benchmark Capital Advisors’s PHARMACYCLICS INC PCYC Stock Holding History

Benchmark Capital Advisors’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,500
Closed -$917K – 132
2014
Q4 		$917K Sell
7,500
-600
-7% -$76.7K 0.62% 53
2014
Q3 		$951K Buy
8,100
+2,800
+53% +$319K 0.66% 52
2014
Q2 		$475K Buy
5,300
+1,500
+39% +$141K 0.3% 84
2014
Q1 		$381K Buy
+3,800
New +$494K 0.26% 89
2013
Q4 		– Sell
-17,250
Closed -$2.38M – 136
2013
Q3 		$2.38M Buy
17,250
+12,350
+252% +$1.37M 1.71% 18
2013
Q2 		$389K Buy
+4,900
New +$400K 0.3% 93

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Benchmark Capital Advisors's PCYC Position: Q1 2015 in Review

Benchmark Capital Advisors sold out of PHARMACYCLICS INC (PCYC) in Q1 2015, closing a stake of 7,500 shares — an estimated $917K sold.

Benchmark Capital Advisors first reported a position in PCYC in Q2 2013 and held it in 6 quarters. The position peaked at $2.38M in Q3 2013. 337 funds tracked by Wall St. Rank hold PCYC as of Q1 2015.

  • Benchmark Capital Advisors reported no remaining PHARMACYCLICS INC position as of Q1 2015 after selling out during the quarter.
  • Benchmark Capital Advisors sold 7,500 PHARMACYCLICS INC shares in Q1 2015, an estimated $917K.
  • Benchmark Capital Advisors first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 6 quarters.
  • Benchmark Capital Advisors's PHARMACYCLICS INC position peaked at $2.38M in Q3 2013.
  • 337 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q1 2015.

Based on Benchmark Capital Advisors's 13F filing for Q1 2015, filed 19 May 2015.